Mindfulness-Based Stress Reduction a Viable Option for Treatment of Anxiety.
Karen Rosenberg
AJN, American Journal of Nursing February 1, 2023 DOI: 10.1097/01.naj.0000919764.55911.7b (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Population | People who have anxiety disorders |
| Interventions | Mindfulness-based stress reduction Escitalopram |
| Topics | Anxiety Meditation |
| Key points | Mindfulness-based stress reduction was well tolerated and had comparable effectiveness to escitalopram, a first-line medication, for anxiety disorders. Study-related adverse events occurred in 78.6% of the escitalopram group and 15.4% of the mindfulness-based stress reduction group. |
Abstract
According to this study: Mindfulness-based stress reduction is well tolerated and has comparable effectiveness to a first-line medication for people who have anxiety disorders.At least one study-related adverse event occurred in 78.6% of patients in the escitalopram group and in 15.4% of those in the mindfulness-based stress reduction group.